Patent · US Expired

Novel substance UCT-1003 and process for producing the same

US5079376A · kind A · utility

0Cited by
1References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 23, 1990
Grant dateJan 7, 1992
Priority date
Expiry dateJan 23, 2010

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12R2001/645
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed is novel compound UCT-1003 represented by the following formula: ##STR1## and having anti-tumor activity. UCT-1003 is produced by culturing a microorganism belonging to the genus Paecilomyces.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.